unsubscribe

To unsubscribe from receiving updates, enter your email address



Lexicon Pharmaceuticals, Inc., is committed to providing helpful and medically relevant information to individuals and members of the healthcare professional community. If you prefer not to receive future updates on XERMELO via the email address that you have previously used to subscribe with us, please enter the email address in the field above and click on the Submit button. If you wish not to receive any future communications from Lexicon Pharmaceuticals, please click here to view our Policies.

Social Image

Important Safety Information and Indication

Important Safety Information and Indication

Important Safety Information

  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. Talk to your doctor if you have these symptoms
  • The most common side effects of XERMELO include nausea, headache, increase in hepatic enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, and fever
  • Talk to your doctor about all medicines you are taking as some may interact with XERMELO

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for Carcinoid Syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

For more information about XERMELO, talk to your doctor or see Full Prescribing Information.

You may report an adverse event related to Lexicon products by calling 1-844-LEX-PHAR (1-844-539-7427)  (US only). If you prefer, you may contact the US Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.